RealTime Bioprocess Raman Analyzer Market

Real-Time Bioprocess Raman Analyzer Market Size

The global real-time bioprocess Raman analyzer market size in 2023 was valued at USD 407.6 million and is set to register growth at 7.4% CAGR from 2024 to 2032. The growth in the market of bioprocess Raman optical spectrometers and transmitters is due to the increasing use of biopharmaceuticals and the need for real-time process monitoring.

Processes used to manage the production of gene therapies, vaccines, and monoclonal antibodies are quite complex. These biopharmaceuticals, alongside the increasing demand for them, fuel the growth in real-time bioprocess Raman analyzers as well. Maintaining nutrient ratios and metabolite concentrations, which are critical quality features of such intricate biologics, is a necessity. For instance, according to the National Institutes of Health, biopharmaceuticals have seen significant growth, with biologics representing around 40% of new medicines approved by the U.S. Food and Drug Administration (FDA) in 2022.

This shows the rising adoption of biologics and the increasing importance of these tools in modern medicine. It demonstrates the urgent need for process control tools such as real-time bioprocess Raman analyzers to maintain desirably high levels of quality and regulatory compliance in the manufacture of sensitive biologic drugs. Biologics are becoming more important, which means that systems for real-time monitoring must be adopted more widely.

A real-time bioprocess Raman analyzer is advanced analytical equipment that utilizes Raman spectroscopy to control and quantify the changes on the chemical and molecular levels within bioprocesses during operations. It uses non-invasive in-line continuous measurement of vibrational modes of molecules and from them determines the concentration of critical parameters such as nutrients, metabolites, and by-products at the time of cell culture and fermentation processes. 

Real-Time Bioprocess Raman Analyzer Market Trends

• Market growth is being accelerated because of recent technological improvements with Raman analyzers and the process of spectroscopy in which the efficiency, accuracy, and applicability of these tools in real-time bioprocess monitoring has been improved.
  
• New Raman analyzers on the market are designed with novel optics and improved detectors which are more sensitive to low-concentration analytes in cells and tissues. Monitoring trace-level molecular changes in real-time is critical to processes such as biopharmaceutical fermentation and cell culture; therefore, these devices make it possible.
  
• Furthermore, the introduction of portable and miniaturized Raman analyzers has increased their use outside of the normal laboratory bioprocessing environments, making them more useful for industrial onsite monitoring of the processes.
  
• These advances increase the speed and accuracy of Raman analyzers and are hence boosting their uptake in industries such as biopharmaceuticals that require quality and efficiency through real-time process monitoring.
  

Real-Time Bioprocess Raman Analyzer Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on product, the market is segmented into Raman analyzer, Raman probes, and software. The Raman analyzer segment dominated the market in 2023 and accounted for USD 166.3 million.

• Raman analyzers are the core technology in real-time bioprocess monitoring. They are all-inclusive with the needed components of spectroscopy to sense and quantify molecular structures, having great biopharmaceutical engineering applications where accuracy is of utmost importance. This is the reason why they dominate the market, and other products such as probes and software are merely supplementary.
  
• Raman analyzers are themselves major software that is used for various bioprocessing stages, including upstream to downstream applications. The ability to measure and monitor important quantities including but not limited to the level of metabolites, the amount of product yielded, and the level of contaminations, automatically sets them as the perfect choice for quality assurance of any biopharmaceutical company.

Learn more about the key segments shaping this market

Download Free PDF

Based on application, the real-time bioprocess Raman analyzer market is segmented into bioprocess analysis and lab to process analysis. The bioprocess analysis segment dominated the market in 2023 with a market share of 68.9%.

• Bioprocess analyzers give manufacturers real-time data enabling them to adjust cell density, nutrient parameters, and product quality and ensure the formed biologics are within the set regulations and efficiency goals. This constant monitoring places bioprocess analysis as the most important use for Raman analyzers.
  
• Furthermore, with the introduction of more complex biopharmaceuticals like cell and gene therapy, and personalized medicine, there is an increasing demand to conduct precise real-time analysis during bioprocessing.
  

Based on end use, the real-time bioprocess Raman analyzer market is segmented into biopharmaceutical companies, contract manufacturing organizations, research organizations, and other end users. The biopharmaceutical companies’ segment is anticipated to reach USD 344.5 million by 2032.

• Real-time Raman analysis enhances production efficiency by providing insights into bioprocess parameters, including nutrient concentrations, product quality, and contamination levels. This enables biopharmaceutical companies to maximize their production efficiency while minimizing their expenses.
  
• Biopharmaceutical companies tend to have higher budgets for investment in these advanced technologies. So, they readily accept Raman analyzers to strengthen their manufacturing processes, enhance efficiency, and cut down costs while competing in the market. This continued investment helps the segment remain strong in the market.

Looking for region specific data?

Download Free PDF

North America dominated the global real-time bioprocess Raman analyzer market in 2023 with a revenue of USD 152.4 million and is projected to reach USD 277.6 million by 2032.

• North America is home to many renowned biopharmaceutical companies which are using Raman analyzers for real-time monitoring and other advanced monitoring technologies to get the best manufacturing processes and meet the strict FDA guidelines.
  
• The FDA drives the adoption of Raman analyzers for optimizing critical biopharmaceutical processes in the region by focusing on an increase in Process Analytical Technology (PAT) in the area.
  

U.S. real-time bioprocess Raman analyzer market was valued at USD 143.7 million in 2023.

• The highly regulated biopharmaceutical industry in the U.S. requires real-time monitoring technologies to ensure consistency, safety, and compliance, increasing the adoption of Raman analyzers in bioprocessing.
  
• Furthermore, as the cell and gene therapy industry grow in the U.S., there is an increasing need for Raman analyzers for non-invasive analytical techniques to analyze these biological processes and quality check the products during manufacturing, which is further driving market growth.
  

UK is anticipated to witness robust growth in the global real-time bioprocess Raman analyzer market.

• The funding and innovative schemes such as the UK BioIndustry Association (BIA) are encouraging UK-based firms to use advanced technology real-time bioprocess monitoring tools like Raman analyzers and are expected to significantly boost biopharmaceutical R&D productivity.
  
• As the pharmaceutical and biopharmaceutical industries in the UK shift focus to continuous manufacturing, using Raman spectroscopic methods are becoming critical to enable continuous monitoring and control of product quality during all phases of processing.
  

Japan is expected to experience high growth in the real-time bioprocess Raman analyzer market during the forecast period.

• There is a growing demand for advanced manufacturing techniques in Japan which include automation and real-time monitoring of bioprocessing, which is making automated Raman analyzers a necessity in the pharmaceutical manufacturing industry.
  
• Japan's significant investments in biopharmaceutical innovations which have increased the incorporation of advanced technologies into healthcare. This has led to greater adoption of Raman analyzers which facilitate accurate and real-time monitoring of bioprocesses, including regenerative medicine and advanced biologics manufacturing.
  

Real-time Bioprocess Raman Analyzer Market Share

The market for real-time bioprocess Raman analyzers is characterized by aggressive competition as the demand for advanced automated solutions continues to increase. Aside from major players within the market, there has been a rise in advanced focused goods such as those in North America that the high technology concentration makes regional advantages clear. Competition focused on integration with automation or AI is one of the other main drivers, with companies merging with hardware suppliers to build more friendly interfaces. So, to remain competitive in this rapidly changing market, continuous product innovation and user onboarding are extremely important.

Real-time Bioprocess Raman Analyzer Market Companies

Prominent players operating in the real-time bioprocess Raman analyzer industry include:

• Agilent Technologies
• B&W Tek
• Bruker Corporation
• Endress+Hauser Group
• Horiba Group
• Indatech - Chauvin Arnoux Group
• MarqMetrix
• Merck
• Metrohm
• METTLER TOLEDO
• Real Time analyzers
• Renishaw
• Sartorius
• Thermo Fisher Scientific
• Wasatch Photonics
  
• Advanced spectroscopy capabilities integrated with Raman technology.
• Comprehensive software platforms for real-time process monitoring.
• Strong global presence and robust service support network.

Real-Time Bioprocess Raman Analyzer Industry News:

• In January 2024, Bruker announced the acquisition of Tornado Spectral Systems Inc., specialized in process Raman instruments. This acquisition is expected to enhance the company's biopharma PAT portfolio and generate revenue for the company.
  
• In April 2022, Thermo Fisher Scientific launched the Thermo Scientific Ramina Process Analyzer, designed to eliminate complexity inherent to Raman spectroscopy measurements. This launch enabled the company to increase their customer base and improve their competitiveness in the market.
  

The real-time bioprocess Raman analyzer market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Raman analyzers
  • Benchtop Raman analyzers
  • Portable Raman analyzers
  • On-line Raman analyzers
  • In-line Raman analyzers 
• Raman probes
• Software

Market, By Application

• Bioprocess analysis
• Lab to process analysis

Market, By End Use

• Biopharmaceutical companies
• Contract manufacturing organizations
• Research organizations
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada 
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE